APA (7th ed.) Citation

J, A., O, D., I, P., RJE, S., TS, S., & BJA, L. (2025). Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani et al.-The Authors' Reply. Journal of cachexia, sarcopenia and muscle, 16(5), e70069. https://doi.org/10.1002/jcsm.70069

Chicago Style (17th ed.) Citation

J, Arends, Dajani O, Philips I, Skipworth RJE, Solheim TS, and Laird BJA. "Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani Et al.-The Authors' Reply." Journal of Cachexia, Sarcopenia and Muscle 16, no. 5 (2025): e70069. https://doi.org/10.1002/jcsm.70069.

MLA (9th ed.) Citation

J, Arends, et al. "Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani Et al.-The Authors' Reply." Journal of Cachexia, Sarcopenia and Muscle, vol. 16, no. 5, 2025, p. e70069, https://doi.org/10.1002/jcsm.70069.